Why the study?
Does an 80-lead ECG body surface mapping system improve the detection of MI and ACS compared to a standard 12-lead ECG in patients presenting to the emergency department with chest pain without STEMI?
Does an 80-lead ECG body surface mapping system improve the detection of MI and ACS compared to a standard 12-lead ECG in patients presenting to the emergency department with chest pain without STEMI?
The 80-lead body surface mapping ECG provides incremental sensitivity over the standard 12-lead ECG for detecting MI and ACS in emergency department patients with chest pain without STEMI, while maintaining high specificity.
No takes yet. Share an insight, caveat, or question.
Should not yet change ED ECG protocols; leaves open whether 80-lead mapping improves outcomes in prospective trials.
O’Neil et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: